Azenta, Inc.

Azenta sells primarily to life sciences and biopharma organizations that need secure, traceable sample storage and handling. Its customers include pharmaceutical and biotechnology companies, academic and government research institutions, and clinical or laboratory operators that manage large volumes of biological samples. These buyers value chain-of-custody integrity, temperature control, automation, and regulatory compliance because sample loss or contamination can be costly and scientifically damaging. The company also serves customers outside the United States, so trade policy, logistics, and local regulatory requirements can affect purchasing and deployment decisions.

Azenta’s near-term focus appears centered on stabilizing operations, remediating internal control weaknesses, and protecting supply continuity in the face of tariff and geopolitical risk. The company also needs to preserve customer trust in sample integrity and service reliability, since its products are used in mission-critical research and clinical workflows. Managing third-party manufacturing relationships, especially in China, is strategically important because it affects lead times, quality control, and the ability to respond to regulatory changes such as the BIOSECURE Act. Over the medium term, the business likely depends on maintaining its installed base, expanding service content, and keeping its sample-management platform relevant to biopharma and research customers.